These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 11908872)
21. Epithelial differentiation in gliomas, meningiomas and choroid plexus papillomas. Cruz-Sánchez FF; García-Bachs M; Rossi ML; Rodríguez-Prados S; Ferrer I; Coakham HB; Ferreres JC; Figols J; Palacin A Virchows Arch B Cell Pathol Incl Mol Pathol; 1992; 62(1):25-34. PubMed ID: 1352072 [TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical markers for intracranial ependymoma recurrence. An analysis of 88 cases. Korshunov A; Golanov A; Timirgaz V J Neurol Sci; 2000 Aug; 177(1):72-82. PubMed ID: 10967185 [TBL] [Abstract][Full Text] [Related]
23. Prognostic relevance of localization and grading in intracranial ependymomas of childhood. Ernestus RI; Schröder R; Stützer H; Klug N Childs Nerv Syst; 1996 Sep; 12(9):522-6. PubMed ID: 8906366 [TBL] [Abstract][Full Text] [Related]
24. Ki67 index in intracranial ependymoma: a promising histopathological candidate biomarker. Preusser M; Heinzl H; Gelpi E; Höftberger R; Fischer I; Pipp I; Milenkovic I; Wöhrer A; Popovici F; Wolfsberger S; Hainfellner JA Histopathology; 2008 Jul; 53(1):39-47. PubMed ID: 18613924 [TBL] [Abstract][Full Text] [Related]
25. Supratentorial extraventricular ependymal neoplasms: a clinicopathologic study of 32 patients. Shuangshoti S; Rushing EJ; Mena H; Olsen C; Sandberg GD Cancer; 2005 Jun; 103(12):2598-605. PubMed ID: 15861411 [TBL] [Abstract][Full Text] [Related]
26. [Proliferative activity of ependymomas. (Quantitative analysis of the expression of Ki67 and AgNOR)]. Ferraraccio F; Accardo M; Cuccurullo L Pathologica; 1995 Apr; 87(2):112-20. PubMed ID: 8532401 [TBL] [Abstract][Full Text] [Related]
27. Prognostic relevance of TP53 mutations, p53 protein, Ki-67 index and conventional histological grading in oligodendrogliomas. Hagel C; Krog B; Laas R; Stavrou DK J Exp Clin Cancer Res; 1999 Sep; 18(3):305-9. PubMed ID: 10606174 [TBL] [Abstract][Full Text] [Related]
28. [Intracranial ependymomas in adult patients. Diagnosis and histological prognostic factors]. Figarella-Branger D; Metellus P; Barrié M; Maues de Paula A; Fernandez C; Polivka M; Vital A; Labrousse F; Vignaud JM; Laquerrière A; Rousselet MC; Lacroix C; Saikali S; Chapon F; Gontier MF; Chrétien F; Babin P; Rigau V; Vandenbos F; Peoc'h M; Kujas M; Chinot O; Gouvernet J; Giorgi R; Guyotat J; Jouvet A Neurochirurgie; 2007 Jun; 53(2-3 Pt 1):76-84. PubMed ID: 17445840 [TBL] [Abstract][Full Text] [Related]
29. Survival and Prognostic Factors of Adult Intracranial Ependymoma: A Single-institutional Analysis of 236 Patients. Zhao F; Wu T; Wang LM; Zhang J; Zhang H; Li SW; Zhang S; Li P; Wang B; Luo L; Liu PN Am J Surg Pathol; 2021 Jul; 45(7):979-987. PubMed ID: 33739788 [TBL] [Abstract][Full Text] [Related]
30. The histologic grade is a main prognostic factor for patients with intracranial ependymomas treated in the microneurosurgical era: an analysis of 258 patients. Korshunov A; Golanov A; Sycheva R; Timirgaz V Cancer; 2004 Mar; 100(6):1230-7. PubMed ID: 15022291 [TBL] [Abstract][Full Text] [Related]
31. A case of cervicomedullary junction tanycytic ependymoma associated with marked cyst formation. Ito T; Ozaki Y; Nakagawara J; Nakamura H; Tanaka S; Nagashima K Brain Tumor Pathol; 2005; 22(1):29-33. PubMed ID: 18095101 [TBL] [Abstract][Full Text] [Related]
32. A study of proliferative markers and tumor suppressor gene proteins in different grades of ependymomas. Sharma MC; Ghara N; Jain D; Sarkar C; Singh M; Mehta VS Neuropathology; 2009 Apr; 29(2):148-55. PubMed ID: 18721229 [TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical study of Ki-67 (MIB-1), p53 protein, p21WAF1, and p27KIP1 expression in benign, atypical, and anaplastic meningiomas. Amatya VJ; Takeshima Y; Sugiyama K; Kurisu K; Nishisaka T; Fukuhara T; Inai K Hum Pathol; 2001 Sep; 32(9):970-5. PubMed ID: 11567227 [TBL] [Abstract][Full Text] [Related]
34. Nucleolin overexpression is associated with an unfavorable outcome for ependymoma: a multifactorial analysis of 176 patients. Chen C; Chen L; Yao Y; Qin Z; Chen H J Neurooncol; 2016 Mar; 127(1):43-52. PubMed ID: 26615563 [TBL] [Abstract][Full Text] [Related]
35. p14ARF protein (FL-132) immunoreactivity in intracranial ependymomas and its prognostic significance: an analysis of 103 cases. Korshunov A; Golanov A; Timirgaz V Acta Neuropathol; 2001 Sep; 102(3):271-7. PubMed ID: 11585252 [TBL] [Abstract][Full Text] [Related]
36. Transformation in recurrent ovarian granulosa cell tumors: Ki67 (MIB-1) and p53 immunohistochemistry demonstrates a possible molecular basis for the poor histopathologic prediction of clinical behavior. Costa MJ; Walls J; Ames P; Roth LM Hum Pathol; 1996 Mar; 27(3):274-81. PubMed ID: 8600043 [TBL] [Abstract][Full Text] [Related]
37. Clinical significance of the histological and molecular characteristics of ependymal tumors: a single institution case series from China. Xi S; Sai K; Hu W; Wang F; Chen Y; Wang J; Zeng J; Chen Z BMC Cancer; 2019 Jul; 19(1):717. PubMed ID: 31324163 [TBL] [Abstract][Full Text] [Related]
38. Accumulation of p53 and Ki-67 expression do not predict survival in patients with fibrillary astrocytomas or the response of these tumors to radiotherapy. Mastronardi L; Puzzilli F; Guiducci A Neurosurgery; 1998 Dec; 43(6):1496. PubMed ID: 9848870 [No Abstract] [Full Text] [Related]
39. The clinical and prognostic relevance of grading in intracranial ependymomas. Ernestus RI; Schröder R; Stützer H; Klug N Br J Neurosurg; 1997 Oct; 11(5):421-8. PubMed ID: 9474274 [TBL] [Abstract][Full Text] [Related]
40. Survivin expression in intracranial ependymomas and its correlation with tumor cell proliferation and patient outcome. Preusser M; Wolfsberger S; Czech T; Slavc I; Budka H; Hainfellner JA Am J Clin Pathol; 2005 Oct; 124(4):543-9. PubMed ID: 16146813 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]